[Platelet function study in primary Raynaud's phenomenon and Raynaud's phenomenon associated with scleroderma]

Area of Science:

• Hematology
• Rheumatology
• Immunology

Background:

• Raynaud's phenomenon (RP) is a condition affecting blood vessels, often linked with autoimmune diseases.
• Platelet activation and aggregation play roles in vascular health and disease pathogenesis.
• Distinguishing between primary RP and RP associated with diffuse scleroderma (DS) is crucial for understanding disease mechanisms.

Purpose of the Study:

• To investigate platelet function differences in patients with primary RP versus RP associated with DS.
• To compare platelet activation markers and aggregation potential between RP patient groups and healthy controls.

Main Methods:

• Evaluated beta-thromboglobulin (BTG) and platelet factor 4 (PF4) plasma levels in 59 RP patients and 20 controls.
• Assessed platelet aggregation induced by adenosine diphosphate (ADP), collagen, and arachidonic acid.
• Compared findings between primary RP, RP with DS, and healthy control groups.

Main Results:

• Patients with RP associated with DS exhibited significantly higher BTG and PF4 levels compared to primary RP and controls (p<0.02).
• The BTG/PF4 ratio was notably greater in the DS group (p<0.005).
• Platelets from DS patients showed enhanced aggregation with ADP (p<0.03) compared to primary RP patients.

Conclusions:

• Patients with RP associated with DS demonstrate in vivo platelet activation and heightened platelet aggregation.
• Primary RP patients do not show these platelet abnormalities, suggesting distinct pathophysiological pathways.
• These findings highlight the role of platelet dysfunction in the pathogenesis of RP with diffuse scleroderma.